High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy
- PMID: 28383390
- PMCID: PMC6404536
- DOI: 10.1097/INF.0000000000001597
High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy
Abstract
A survey of 461 HIV-infected Kenyan children receiving antiretroviral therapy found 143 (31%) failing virologically. Drug resistance mutations were found in 121; 37 had L74V/I mutations, with 95% receiving abacavir (ABC)-containing regimens. L74V/I was associated with current ABC usage (P = 0.0001). L74V/I may be more prevalent than previously realized in children failing ABC-containing regimens, even when time on treatment has been short. Ongoing rigorous pediatric drug resistance surveillance is needed.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- The Gap Report . Geneva: Joint United Nations Programme on HIV/AIDS; 2014.
-
- Kenya Antiretroviral Medicines Stock Situation Report. Nairobi: National AIDS and STI Control Programme; 2015.
-
- Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Rapid Advice. Nairobi: National AIDS and STI Control Programme; 2014.
-
- Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommnedations for a Public Health Approach. Geneva: World Health Organization; 2013. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical